Consistent with this finding, higher expression of B-cell-associated gene signatures such as CD79A, MS4A1, IGHD and FCRL4 favored the survival in NPC patients, suggesting potential anti-NPC immunity by NPC-infiltrating B-cells (17). This evidence concerns the gene MS4A1 and nasopharyngeal carcinoma.